Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States.

The Journal of Clinical Hypertension
Brent M EganAngelo Sinopoli

Abstract

The US Preventive Services Task Force cholesterol guideline recommended statins for fewer adults than the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline by setting a higher 10-year atherosclerotic cardiovascular disease threshold (≥10.0% vs ≥7.5%) and requiring concomitant diabetes mellitus, hypertension, dyslipidemia, or cigarette smoking. The 2017 ACC/AHA hypertension guideline lowered the hypertension threshold, increasing 2016 guideline statin-eligible adults. Cross-sectional data on US adults aged 40 to 75 years enabled estimated numbers for the 2013 guideline and 2016 guideline with hypertension thresholds of ≥140/≥90 mm Hg and ≥130/80 mm Hg, respectively, on: (1) untreated, statin-eligible adults for primary atherosclerotic cardiovascular disease prevention (25.40, 14.72, 15.35 million); (2) atherosclerotic cardiovascular disease events prevented annually (124 000, 70 852, 73 199); (3) number needed to treat (21, 21, 21); and (4) number needed to harm (38, 143, 143) per 1000 patient-years for incident diabetes mellitus (42 800, 6700, 7100 cases per year). Despite the lower hypertension threshold, the 2013 cholesterol guideline qualifies approximately 10 million more adults for statins ...Continue Reading

References

Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Mar 27, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S Levey, Lesley A Stevens
Jan 25, 2011·Cardiology Clinics·Joel A Lardizabal, Prakash Deedwania
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Mar 8, 2012·Circulation. Cardiovascular Quality and Outcomes·Joshua I BarzilayUNKNOWN ALLHAT Collaborative Research Group
Mar 5, 2013·Current Diabetes Reports·Mark R Goldstein, Luca Mascitelli
Jul 12, 2013·JAMA : the Journal of the American Medical Association·Christopher J L MurrayUNKNOWN U.S. Burden of Disease Collaborators
Mar 22, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A InkerHarold I Feldman
May 31, 2014·BMJ : British Medical Journal·Colin R DormuthUNKNOWN Canadian Network for Observational Drug Effect Studies Investigators
Jul 15, 2015·JAMA : the Journal of the American Medical Association·Ankur PandyaThomas A Gaziano
Nov 4, 2015·JAMA : the Journal of the American Medical Association·Elizabeth D KantorEdward L Giovannucci
Aug 21, 2016·Journal of the American Heart Association·Brent M EganAngelo Sinopoli
Nov 14, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceMichael P Pignone
Aug 12, 2017·The American Journal of Cardiology·Yogita RochlaniJawahar L Mehta

❮ Previous
Next ❯

Citations

Jun 18, 2019·European Journal of Preventive Cardiology·Gloria ManyanguGerard Flaherty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

© 2022 Meta ULC. All rights reserved